Literature DB >> 15858023

An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.

Daniele Catalucci1, Elisabetta Sporeno, Agostino Cirillo, Gennaro Ciliberto, Alfredo Nicosia, Stefano Colloca.   

Abstract

Production of multiply deleted adenoviral (Ad) vectors with increased cloning capacity and reduced immunogenicity to adenovirus gene products requires the concomitant generation of efficient packaging cell lines. High expression levels of the complementing genes must be achieved in a coordinated fashion with viral replication. This is a particularly difficult task in light of the significant cytotoxicity displayed by adenoviral proteins. To this end, we developed a novel adenovirus-based amplicon with an Epstein-Barr virus origin of replication, Ad type 5 (Ad5) inverted terminal repeats, all Ad5 early region 2 (E2) genes, and the early region 4 (E4) open reading frame 6 (ORF6) under the control of a tetracycline-dependent promoter. The amplicon (pE2) was stably maintained in multiple copies in the nuclei of 293 cells stably expressing the Epstein-Barr virus nuclear antigen 1 (EBNA1) and allowed replication as a linear DNA upon induction of E2 and ORF6 gene expression. A stable cell line (2E2) was generated by introducing pE2 into 293EBNATet cells expressing the tetracycline-dependent transcriptional silencer and the reverse Tet transactivator (rtTA2). Upon induction with doxicycline, 2E2 cells produced higher levels of polymerase, precursor terminal protein (pTP), and DNA binding protein than noninduced 2E2 cells infected with first-generation Ad5 vector and supported efficient amplification of a multiply deleted Ad5 vector lacking E1, E2, E3, and E4 genes (Ad5DeltaE(1-4)). The high cloning capacity of Ad5DeltaE(1-4) (up to 12.6 kb) was exploited to construct a vector encoding the entire hepatitis C virus (HCV) polyprotein. Infection of HeLa cells by the resulting vector showed high levels of correctly processed HCV proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858023      PMCID: PMC1091673          DOI: 10.1128/JVI.79.10.6400-6409.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.

Authors:  J F Engelhardt; Y Yang; L D Stratford-Perricaudet; E D Allen; K Kozarsky; M Perricaudet; J R Yankaskas; J M Wilson
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

2.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

3.  Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff.

Authors:  D N Halbert; J R Cutt; T Shenk
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

4.  Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates.

Authors:  Stefania Lamartina; Luisa Silvi; Giuseppe Roscilli; Danilo Casimiro; Adam J Simon; Mary-Ellen Davies; John W Shiver; Cira Daniela Rinaudo; Immacolata Zampaglione; Elena Fattori; Stefano Colloca; Odalys Gonzalez Paz; Ralph Laufer; Hermann Bujard; Riccardo Cortese; Gennaro Ciliberto; Carlo Toniatti
Journal:  Mol Ther       Date:  2003-02       Impact factor: 11.454

5.  Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection.

Authors:  M M Huang; P Hearing
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.

Authors:  Danilo R Casimiro; Ling Chen; Tong-Ming Fu; Robert K Evans; Michael J Caulfield; Mary-Ellen Davies; Aimin Tang; Minchun Chen; Lingyi Huang; Virginia Harris; Daniel C Freed; Keith A Wilson; Sheri Dubey; De-Min Zhu; Denise Nawrocki; Henryk Mach; Robert Troutman; Lynne Isopi; Donna Williams; William Hurni; Zheng Xu; Jeffrey G Smith; Su Wang; Xu Liu; Liming Guan; Romnie Long; Wendy Trigona; Gwendolyn J Heidecker; Helen C Perry; Natasha Persaud; Timothy J Toner; Qin Su; Xiaoping Liang; Rima Youil; Michael Chastain; Andrew J Bett; David B Volkin; Emilio A Emini; John W Shiver
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell.

Authors:  D F Klessig; D E Brough; V Cleghon
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

8.  Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products.

Authors:  Daniel C Farley; Jason L Brown; Keith N Leppard
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Covalently closed circles of human adenovirus DNA are infectious.

Authors:  F L Graham
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

10.  Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

Authors:  Nancy J Sullivan; Thomas W Geisbert; Joan B Geisbert; Ling Xu; Zhi-Yong Yang; Mario Roederer; Richard A Koup; Peter B Jahrling; Gary J Nabel
Journal:  Nature       Date:  2003-08-07       Impact factor: 49.962

View more
  10 in total

1.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

Review 2.  Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developments.

Authors:  Philip Wintermeyer; Jack R Wands
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

3.  CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.

Authors:  Daniela Benati; Francesca Miselli; Fabienne Cocchiarella; Clarissa Patrizi; Marta Carretero; Samantha Baldassarri; Virginia Ammendola; Cristina Has; Stefano Colloca; Marcela Del Rio; Fernando Larcher; Alessandra Recchia
Journal:  Mol Ther       Date:  2018-08-04       Impact factor: 11.454

4.  Amino acid exchanges in the putative nuclear export signal of adenovirus type 5 L4-100K severely reduce viral progeny due to effects on hexon biogenesis.

Authors:  Orkide O Koyuncu; Thomas Speiseder; Thomas Dobner; Melanie Schmid
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

5.  Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation.

Authors:  Andrew N Blackford; Rakesh N Patel; Natalie A Forrester; Kathrin Theil; Peter Groitl; Grant S Stewart; A Malcolm R Taylor; Iain M Morgan; Thomas Dobner; Roger J A Grand; Andrew S Turnell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

6.  Decreased Vector Gene Expression from E2b Gene-Deleted Adenovirus Serotype 5 Vaccines Intensifies Proinflammatory Immune Responses.

Authors:  Dionisia Quiroga; Yasser A Aldhamen; Sarah Godbehere; Laura Harding; Andrea Amalfitano
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

7.  Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer.

Authors:  Helenia Ansuini; Annalisa Meola; Zeynep Gunes; Valentina Paradisi; Monica Pezzanera; Stefano Acali; Claudia Santini; Alessandra Luzzago; Federica Mori; Domenico Lazzaro; Gennaro Ciliberto; Alfredo Nicosia; Nicola La Monica; Alessandra Vitelli
Journal:  J Oncol       Date:  2010-01-14       Impact factor: 4.375

8.  Transcriptional activation of the adenoviral genome is mediated by capsid protein VI.

Authors:  Sabrina Schreiner; Ruben Martinez; Peter Groitl; Fabienne Rayne; Remi Vaillant; Peter Wimmer; Guillaume Bossis; Thomas Sternsdorf; Lisa Marcinowski; Zsolt Ruzsics; Thomas Dobner; Harald Wodrich
Journal:  PLoS Pathog       Date:  2012-02-23       Impact factor: 6.823

9.  A Single Amino Acid Switch in the Adenoviral DNA Binding Protein Abrogates Replication Center Formation and Productive Viral Infection.

Authors:  Jana Boddin; Wing-Hang Ip; Britta Wilkens; Konstantin von Stromberg; Wilhelm Ching; Emre Koyuncu; Luca D Bertzbach; Thomas Dobner
Journal:  mBio       Date:  2022-03-07       Impact factor: 7.786

10.  Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.

Authors:  Miona Stubbe; Julia Mai; Christina Paulus; Hans Christian Stubbe; Julia Berscheminski; Maryam Karimi; Samuel Hofmann; Elisabeth Weber; Kamyar Hadian; Ron Hay; Peter Groitl; Michael Nevels; Thomas Dobner; Sabrina Schreiner
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.